Scientists discover a small molecule that halts kidney disease progression
A team of researchers set out to discover the disease pathways of a rare genetic kidney disease and found a compound that stops the disease in its tracks.
List view / Grid view
A team of researchers set out to discover the disease pathways of a rare genetic kidney disease and found a compound that stops the disease in its tracks.
Charles River Laboratories International, Inc. announced the expansion of its CRISPR/Cas9 service offering with the addition of a license from ERS Genomics Limited.
Scientists have provided a therapeutic approach to slow down the progression of neurodegeneration in Alzheimer's disease...
A new weakness found in medulloblastoma could lead to more personalised medicine and improved treatment for some patients.
Reducing a protein found in the mitochondria of cardiac muscle cells initiates cardiac dysfunction and heart failure...
A study has shown that disruption to cell autophagy is involved in the development of pancreatic cancer.
Recent study shows how a microscope using ultraviolet (UV) light to illuminate samples enables pathologists to assess high-resolution images of biopsies and other fresh tissue samples for disease, quickly and effectively.
A new small-molecule drug can restore brain function and memory in a mouse model of Alzheimer's disease by stopping toxic ion flow in the brain...
Researchers have found that amyloid-? facilitates the interaction between the plaques and abnormal tau.
Results from a new study suggest that DNA sequencing could soon become part of the routine diagnostic examination for patients with chronic kidney disease.
Researchers have revealed a protein active during early embryo development called GDF6 plays a primary role in metastatic melanoma...
Scientists may have found possible targets for therapeutic interventions in the fight against Lou Gehrig’s disease.
Human sperm may hold the potential to serve as biomarkers of the future health of newborn infants, according to a new study.
Blood sample, or liquid biopsy, can reveal which patients will respond to checkpoint inhibitor-based immunotherapies...
A stem cell-derived in vitro model displays key small intestine characteristics including innate immune responses.